Published in Front Aging Neurosci on July 19, 2013
Lower serum levels of selenium, copper, and zinc are related to neuromotor impairments in children with konzo. J Neurol Sci (2015) 0.88
The role of brain-derived neurotrophic factor in comorbid depression: possible linkage with steroid hormones, cytokines, and nutrition. Front Psychiatry (2014) 0.85
Lipid rafts: linking prion protein to zinc transport and amyloid-β toxicity in Alzheimer's disease. Front Cell Dev Biol (2014) 0.83
TRPM2 channel deficiency prevents delayed cytosolic Zn2+ accumulation and CA1 pyramidal neuronal death after transient global ischemia. Cell Death Dis (2014) 0.82
Editorial: Metals and neurodegeneration: restoring the balance. Front Aging Neurosci (2015) 0.80
Zinc, aging, and immunosenescence: an overview. Pathobiol Aging Age Relat Dis (2015) 0.79
Pleiotropic roles of metallothioneins as regulators of chondrocyte apoptosis and catabolic and anabolic pathways during osteoarthritis pathogenesis. Ann Rheum Dis (2016) 0.78
Relationship between Zinc (Zn (2+) ) and Glutamate Receptors in the Processes Underlying Neurodegeneration. Neural Plast (2015) 0.78
Concentration-Dependent Dual Mode of Zn Action at Serotonin 5-HT1A Receptors: In Vitro and In Vivo Studies. Mol Neurobiol (2015) 0.78
Zinc inhibits Hedgehog autoprocessing: linking zinc deficiency with Hedgehog activation. J Biol Chem (2015) 0.78
Significance of Low Nanomolar Concentration of Zn(2+) in Artificial Cerebrospinal Fluid. Mol Neurobiol (2016) 0.77
Single Fluorescent Protein-Based Indicators for Zinc Ion (Zn(2+)). Anal Chem (2016) 0.76
Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase. Hum Mol Genet (2016) 0.76
Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches. Oxid Med Cell Longev (2016) 0.76
Obesity and age-related alterations in the gene expression of zinc-transporter proteins in the human brain. Transl Psychiatry (2016) 0.76
Metalloneurochemistry and the Pierian Spring: 'Shallow Draughts Intoxicate the Brain'. Isr J Chem (2016) 0.75
Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity. Neural Plast (2017) 0.75
Zinc deficiency and low enterocyte zinc transporter expression in human patients with autism related mutations in SHANK3. Sci Rep (2017) 0.75
Decreased circulating Zinc levels in Parkinson's disease: a meta-analysis study. Sci Rep (2017) 0.75
Enhanced oxidative stress resistance through activation of a zinc deficiency transcription factor in Brachypodium distachyon. Plant Physiol (2014) 0.75
Alterations of Bio-elements, Oxidative, and Inflammatory Status in the Zinc Deficiency Model in Rats. Neurotox Res (2015) 0.75
Zinc transporters and dysregulated channels in cancers. Front Biosci (Landmark Ed) (2017) 0.75
Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A (1985) 16.10
Rapid induction of Alzheimer A beta amyloid formation by zinc. Science (1994) 5.34
Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci (1998) 4.19
National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24
Mammalian zinc transport, trafficking, and signals. J Biol Chem (2006) 3.05
Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol (2008) 3.03
Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem (2010) 3.02
Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr (2009) 2.91
Mammalian zinc transporters. Annu Rev Nutr (2004) 2.82
Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse. Neuron (2008) 2.64
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med (2001) 2.63
Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol (1989) 2.49
Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine (1997) 2.43
Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem (2000) 2.29
Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron (2004) 2.17
Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr (2000) 2.16
Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol (2005) 2.15
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis (2008) 2.13
The essential toxin: impact of zinc on human health. Int J Environ Res Public Health (2010) 2.09
Zinc at glutamatergic synapses. Neuroscience (2008) 2.08
The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron (1991) 2.05
Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry (1994) 1.91
Modulation of mitochondrial function by endogenous Zn2+ pools. Proc Natl Acad Sci U S A (2003) 1.90
Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry (2003) 1.89
Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J Biol Chem (1997) 1.88
Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A (2002) 1.68
Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers. Eur J Clin Invest (1999) 1.63
Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci (2000) 1.59
Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol (2004) 1.59
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. J Alzheimers Dis (2010) 1.57
Movement of zinc and its functional significance in the brain. Brain Res Brain Res Rev (2000) 1.48
Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J Neurosci (1994) 1.48
The neurophysiology and pathology of brain zinc. J Neurosci (2011) 1.46
Zn2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist (2004) 1.46
Functional significance of zinc-related signaling pathways in immune cells. Annu Rev Nutr (2009) 1.46
Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology (1988) 1.44
Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res (2000) 1.42
Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus. J Neurosci (2009) 1.41
Elevated cortical zinc in Alzheimer disease. Neurology (2006) 1.38
Metallothionein I and II protect against zinc deficiency and zinc toxicity in mice. J Nutr (1996) 1.32
The SLC30 family of zinc transporters - a review of current understanding of their biological and pathophysiological roles. Mol Aspects Med (2013) 1.32
Activation of the Trk signaling pathway by extracellular zinc. Role of metalloproteinases. J Biol Chem (2005) 1.26
Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J Exp Med (2002) 1.24
The zinc/thiolate redox biochemistry of metallothionein and the control of zinc ion fluctuations in cell signaling. Arch Biochem Biophys (2007) 1.22
Brain, aging and neurodegeneration: role of zinc ion availability. Prog Neurobiol (2005) 1.17
Modulation of A beta adhesiveness and secretase site cleavage by zinc. J Biol Chem (1994) 1.13
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death Dis (2010) 1.11
Metallothionein III is reduced in Alzheimer's disease. Brain Res (2001) 1.10
Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study. Eur J Clin Nutr (2005) 1.09
Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol (2004) 1.09
Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide. J Biol Chem (2007) 1.08
Hypozincemia in depression. J Affect Disord (1994) 1.08
Zinc neurotoxicity in cortical cell culture. Neuroscience (1988) 1.07
Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav (2008) 1.05
Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord (2009) 1.05
Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J Neurosci Methods (1997) 1.05
Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem (1996) 1.05
Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain. Neuroscience (2006) 1.05
Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Int J Biochem Cell Biol (2003) 1.04
Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry. J Neurol Sci (2002) 1.04
Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm (Vienna) (1998) 1.03
Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J Trace Elem Med Biol (2010) 1.02
Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids (2008) 1.02
Decreased brain zinc availability reduces hippocampal neurogenesis in mice and rats. J Cereb Blood Flow Metab (2009) 0.99
Enhanced zinc consumption causes memory deficits and increased brain levels of zinc. Physiol Behav (2004) 0.99
Zinc in depressive disorder. Acta Psychiatr Scand (1990) 0.99
The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Neurobiol Aging (2004) 0.98
Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability. Biometals (2009) 0.98
Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. EMBO J (1992) 0.97
Correlation between dietary zinc intakes and its serum levels with depression scales in young female students. Biol Trace Elem Res (2009) 0.97
Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology (1989) 0.97
Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease. Am J Alzheimers Dis Other Demen (2010) 0.96
Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res (2003) 0.96
Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull (2003) 0.96
The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.96
Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease. Exp Gerontol (2007) 0.96
Elemental imbalances in the olfactory pathway in Alzheimer's disease. J Neurol Sci (1995) 0.95
Antidepressant-like activity of zinc: further behavioral and molecular evidence. J Neural Transm (Vienna) (2008) 0.94
Randomized trial of the effect of zinc supplementation on the mental health of school-age children in Guatemala. Am J Clin Nutr (2010) 0.94
Increased inflammatory response in aged mice is associated with age-related zinc deficiency and zinc transporter dysregulation. J Nutr Biochem (2012) 0.94
Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Res (1990) 0.94
Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain. Brain Pathol (2009) 0.94
Zinc deficiency reduces neurogenesis accompanied by neuronal apoptosis through caspase-dependent and -independent signaling pathways. Neurotox Res (2009) 0.93
Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res (1994) 0.93
Presenilins promote the cellular uptake of copper and zinc and maintain copper chaperone of SOD1-dependent copper/zinc superoxide dismutase activity. J Biol Chem (2011) 0.92
Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord (2010) 0.92
Association of zinc deficiency and depression in the patients with end-stage renal disease on hemodialysis. J Ren Nutr (2010) 0.91
Subclinical zinc deficiency impairs human brain function. J Trace Elem Med Biol (2012) 0.91
Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain. Brain Res Bull (2008) 0.91
Zinc homeostasis in the hippocampus of zinc-deficient young adult rats. Neurochem Int (2004) 0.91
Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease. Neurotox Res (2005) 0.91
Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice. PLoS One (2011) 0.91
A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease. J Alzheimers Dis (2009) 0.90
Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol Rep (2006) 0.90
Zinc and Alzheimer's disease: is there a direct link? Brain Res Brain Res Rev (1997) 0.90
Hippocampal tin, aluminum and zinc in Alzheimer's disease. Biometals (1993) 0.90
Cell type-specific action of seizure-induced intracellular zinc accumulation in the rat hippocampus. J Physiol (2005) 0.89
Serum zinc levels and Alzheimer's disease. Biol Trace Elem Res (2000) 0.89
Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain. Neurobiol Aging (2008) 0.88
Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations. Neurology (1983) 0.88